4.2 Article

Japanese Leigh syndrome case treated with EPI-743

期刊

BRAIN & DEVELOPMENT
卷 40, 期 2, 页码 145-149

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.braindev.2017.08.005

关键词

Leigh syndrome; EPI-743; Succinate; Mitochondria DNA

资金

  1. Agency of Medical Research and Development
  2. JSPS KAKENHI [15552768]

向作者/读者索取更多资源

Background: Leigh syndrome is a mitochondria] disease caused by respiratory chain deficiency, and there are no proven effective therapies. EPI-743 is a potent cellular oxidative stress protectant and results of clinical trials for mitochondria] diseases are accumulating. Case: At 5 months, a girl presented with the scarce eye movement and diminished muscle tone. She was diagnosed with Leigh encephalopathy from blood and cerebrospinal fluid lactate elevation and MRI findings. Sequence analysis for mitochondria] DNA revealed a T10158C mutation in the mitochondrial encoded ND3 gene in complex I. Results: At 8 months, succinate was prescribed expected to restore the electron transport chain system. After that her condition got worse and succinate was discontinued. Subsequent administration of EPI-743 improved her eye movement, fine motor movements of the extremities, and bowel movement. She is now 5 years old. Although brain atrophy has progressed, she has still respiratory free time. Conclusion: Our patient showed visible improvement with EPI-743 treatment and the only patient surviving after 4 years. There is a possibility that EPI-743 is modifying the natural course of the syndrome. (C) 2017 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据